Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study

Antimicrob Agents Chemother. 1997 Jun;41(6):1389-91. doi: 10.1128/AAC.41.6.1389.

Abstract

Serum bactericidal activity against a penicillin-susceptible strain and a penicillin-resistant strain of Streptococcus pneumoniae (amoxicillin and cefotaxime MICs, 0.001 and 1 microg/ml, respectively, and MBCs, 0.01 and 2 microg/ml, respectively) was measured in 12 healthy volunteers who each received an oral 875-mg dose of amoxicillin and an intramuscular 1-g dose of cefotaxime in a crossover fashion. The areas under the bactericidal activity-time curves for the two strains were found to be similar for both antibiotics despite the significantly higher (P < 0.002) AUC/MIC and peak level/MIC values for cefotaxime.

Publication types

  • Clinical Trial
  • Clinical Trial, Phase I
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Amoxicillin / blood
  • Amoxicillin / pharmacokinetics
  • Amoxicillin / pharmacology*
  • Cefotaxime / blood
  • Cefotaxime / pharmacokinetics
  • Cefotaxime / pharmacology*
  • Cephalosporins / blood
  • Cephalosporins / pharmacokinetics
  • Cephalosporins / pharmacology*
  • Cross-Over Studies
  • Humans
  • Male
  • Penicillin Resistance
  • Penicillins / blood
  • Penicillins / pharmacokinetics
  • Penicillins / pharmacology*
  • Serum Bactericidal Test*
  • Streptococcus pneumoniae / drug effects*

Substances

  • Cephalosporins
  • Penicillins
  • Amoxicillin
  • Cefotaxime